Cargando…
Sentinel Lymph-Node Biopsy in Early-Stage Cervical Cancer: The 4-Year Follow-Up Results of the Senticol 2 Trial
INTRODUCTION: Senticol 2 is a randomized multicenter trial in the treatment of early-stage cervical cancer patients. The aim of the Senticol 2 study was to compare the effect of sentinel-lymph-node biopsy (SLNB) to that of SLNB + pelvic lymphadenectomy (PLND), and to determine the postoperative lymp...
Autores principales: | Favre, Guillaume, Guani, Benedetta, Balaya, Vincent, Magaud, Laurent, Lecuru, Fabrice, Mathevet, Patrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927597/ https://www.ncbi.nlm.nih.gov/pubmed/33680944 http://dx.doi.org/10.3389/fonc.2020.621518 |
Ejemplares similares
-
The Clinical Impact of Low-Volume Lymph Nodal Metastases in Early-Stage Cervical Cancer: The Senticol 1 and Senticol 2 Trials
por: Guani, Benedetta, et al.
Publicado: (2020) -
Predictors of Non-Sentinel Lymph Node Metastasis in Patients with Positive Sentinel Lymph Node in Early-Stage Cervical Cancer: A SENTICOL GROUP Study
por: Pache, Basile, et al.
Publicado: (2023) -
Can Conization Specimens Predict Sentinel Lymph Node Status in Early-Stage Cervical Cancer? A SENTICOL Group Study
por: Balaya, Vincent, et al.
Publicado: (2021) -
Histopathologic Validation of the Sentinel Node Technique for Early-Stage Cervical Cancer Patients
por: Mathevet, Patrice, et al.
Publicado: (2020) -
Lymph Node Involvement in Early-Stage Cervical Cancer: Is Lymphangiogenesis a Risk Factor? Results from the MICROCOL Study
por: Tantari, Matteo, et al.
Publicado: (2022)